Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Postgraduate Medicine
|
December 24, 1997
Fireworks over fibromyalgia, CFS, and IBS
C R Chambers
The Canadian Journal of Hospital Pharmacy
|
February 1, 1995
Leucovorin taste challenge
C R Chambers, D McIntosh
The Canadian Journal of Hospital Pharmacy
|
April 1, 1995
An evaluation of verbal and written methods in counselling cancer patients
D Bates, D McIntosh, C R Chambers
The Canadian Journal of Hospital Pharmacy
|
June 1, 1992
Comprehensive clinical pharmacy documentation in an out-patient cancer facility
N M Davies, J R Spaven, C R Chambers
The British Journal of Dermatology
|
October 20, 2004
Hepatoerythropoietic porphyria: a missense mutation in the UROD gene is associated with mild disease and an unusual porphyrin excretion pattern
D K B Armstrong, P C Sharpe, C R Chambers, et al.
Current Oncology (Toronto, Ont.)
|
March 18, 2016
Estimation of drug cost avoidance and pathology cost avoidance through participation in NCIC Clinical Trials Group phase III clinical trials in Canada
P A Tang, A E Hay, C J O'Callaghan, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Postgraduate Medicine
|
December 24, 1997
Fireworks over fibromyalgia, CFS, and IBS
C R Chambers
The Canadian Journal of Hospital Pharmacy
|
February 1, 1995
Leucovorin taste challenge
C R Chambers, D McIntosh
The Canadian Journal of Hospital Pharmacy
|
April 1, 1995
An evaluation of verbal and written methods in counselling cancer patients
D Bates, D McIntosh, C R Chambers
The Canadian Journal of Hospital Pharmacy
|
June 1, 1992
Comprehensive clinical pharmacy documentation in an out-patient cancer facility
N M Davies, J R Spaven, C R Chambers
The British Journal of Dermatology
|
October 20, 2004
Hepatoerythropoietic porphyria: a missense mutation in the UROD gene is associated with mild disease and an unusual porphyrin excretion pattern
D K B Armstrong, P C Sharpe, C R Chambers, et al.
Current Oncology (Toronto, Ont.)
|
March 18, 2016
Estimation of drug cost avoidance and pathology cost avoidance through participation in NCIC Clinical Trials Group phase III clinical trials in Canada
P A Tang, A E Hay, C J O'Callaghan, et al.
Page
of 1